NCT Number: NCT00134147
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Looking for future studies?
Notify MeKey information
Conditions
Age range
35 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Pfizer Investigational Site, Calgary, Alberta, Canada
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diabetes mellitus Type 2
- Failing two or more oral anti-diabetic agents
Exclusion criteria
- Asthma, COPD
- Smoking
Treatment and study plan
Primary outcomes
-
Glycosylated hemoglobin
Secondary outcomes
-
Percent of patients achieving good control of fasting glucose and lipids
-
Rate of hypoglycemia
-
Changes in body weight
-
Patient satisfaction
-
Safety based on adverse events reported and laboratory tests
Sponsors and collaborators
Lead sponsor
Pfizer
Industry
Collaborators
- Sanofi
Registry information
Official study title
A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents
Important dates
- Study start
- 2005
- Study completion
- 2007
- First posted
- Aug 24, 2005
- Registry last updated
- Apr 17, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Diabetes Prevention Program Outcomes Study
NCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsA Sugar-Sweetened Beverage Reduction Intervention for Native American Men
NCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsLinks Between Inflammation and Cardiometabolic Diseases
NCT01934660
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsCold Spray for Insulin-Injection Pain in the Emergency Department
NCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial Details